← FDA Drug Approvals (Drugs@FDA)

SPIRONOLACTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRAVITI PHARMS · Approved 2025-01-23

Drug application

FDA Application #

ANDA219494

Application type

Abbreviated New Drug Application (Generic)

Brand name

SPIRONOLACTONE

Generic name

SPIRONOLACTONE

Active ingredients

SPIRONOLACTONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GRAVITI PHARMS

Manufacturer

Rising Pharma Holdings, Inc.

First approval

2025-01-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown